TY - JOUR
T1 - Total skin-sparing mastectomy without preservation of the nipple-areola complex
AU - Margulies, Aaron G.
AU - Hochberg, Julio
AU - Kepple, Julie
AU - Henry-Tillman, Ronda S.
AU - Westbrook, Kent
AU - Klimberg, V. Suzanne
PY - 2005/12
Y1 - 2005/12
N2 - Background: We hypothesized that total skin-sparing mastectomy (TSM) including where the skin overlying the nipple and areola is preserved would be oncologically safe and facilitate improved cosmetic reconstruction. Methods: A review (May 2003 through January 2005) was completed on all procedures that were performed through an inframammary incision or a previous scar with reconstruction using Botox, AlloDerm, and a subpectoral tissue implant. Results: Thirty-one patients had 50 TSMs. Twelve percent (6/50) of TSMs had the skin of the nipple and areola resected: 4 (14% of tumors) because of tumor involvement and 2 (4%) because of skin necrosis. Fourteen percent of patients had other complications: 4% (2/50) had infection and/or flap necrosis and 10% (5/50) had superficial epidermolysis requiring no intervention, for a total complication rate of 18%. Average cosmetic score was 8.5 (range 4 to 10). No recurrences are evident after mean follow-up of 7.9 ± 5.4 months. Conlusion: Our short-term experience suggests that TSM has an acceptable complication rate, is theoretically oncologically safe, and facilitates an improved cosmetic result.
AB - Background: We hypothesized that total skin-sparing mastectomy (TSM) including where the skin overlying the nipple and areola is preserved would be oncologically safe and facilitate improved cosmetic reconstruction. Methods: A review (May 2003 through January 2005) was completed on all procedures that were performed through an inframammary incision or a previous scar with reconstruction using Botox, AlloDerm, and a subpectoral tissue implant. Results: Thirty-one patients had 50 TSMs. Twelve percent (6/50) of TSMs had the skin of the nipple and areola resected: 4 (14% of tumors) because of tumor involvement and 2 (4%) because of skin necrosis. Fourteen percent of patients had other complications: 4% (2/50) had infection and/or flap necrosis and 10% (5/50) had superficial epidermolysis requiring no intervention, for a total complication rate of 18%. Average cosmetic score was 8.5 (range 4 to 10). No recurrences are evident after mean follow-up of 7.9 ± 5.4 months. Conlusion: Our short-term experience suggests that TSM has an acceptable complication rate, is theoretically oncologically safe, and facilitates an improved cosmetic result.
KW - AlloDerm
KW - Botox
KW - Breast reconstruction
KW - Nipple involvement
KW - Nipple-areolar complex
KW - Skin-sparing mastectomy
UR - http://www.scopus.com/inward/record.url?scp=27944487909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27944487909&partnerID=8YFLogxK
U2 - 10.1016/j.amjsurg.2005.08.019
DO - 10.1016/j.amjsurg.2005.08.019
M3 - Article
C2 - 16307944
AN - SCOPUS:27944487909
SN - 0002-9610
VL - 190
SP - 920
EP - 926
JO - American Journal of Surgery
JF - American Journal of Surgery
IS - 6
ER -